Micro Ophthalmic Ocular Implants

Micro Ophthalmic Ocular Implants

Articles, Isometric
Micro Ophthalmic Ocular Implants Donna Bibber shares insight about micro ophthalmic ocular implants and the continued impact of micro mold manufacturing on worldwide growth in the next five years. Micro ophthalmic and intraocular implants continue to be one of the largest and fastest-growing global micro medical and pharma micro device market sectors. Driven by a baby boomer aging population, technology innovations, and vast, rapidly emerging markets in China and India, the ophthalmic devices sector is expected to attain a double-digit growth. Age-related eye diseases such as cataracts, diabetic retinopathy, glaucoma and macular degeneration (to name only a few) continue to cause significant or complete loss of vision.  Since ophthalmic and intraocular implants are largely made up of many micro-sized and highly precise components and assemblies, it's easy to understand the…
Read More
Scalability of Micro-Intraocular Implants and Devices

Scalability of Micro-Intraocular Implants and Devices

Articles, Isometric
Scalability of Micro-Intraocular Implants and Devices Donna Bibber discusses some of these micro-intraocular implants and devices and the scalability challenges associated with each, from the perspective of a plastics engineer. Recent developments and new-to-market intra-ocular devices and implants have led to the successful treatment of a number of ophthalmological conditions of varying seriousness and complexity such as: Glaucoma Cataracts Retinal detachment Diabetic retinopathy Age-related macular degeneration Uveitis Dry-eye syndrome. Treatment of these conditions often requires collaboration between ophthalmological surgeons, pharmacologists, and micro-specific contract manufacturers. Development of these devices and implants occurs through a large number of highly focused, research-driven specialists, including and micro fabrication specialists, such as: Small, innovation-support funding programs Development companies that easily find a large marketing partner Big pharma funding the outsources of the development instead of…
Read More